e-learning
resources
Paris 2018
Monday, 17.09.2018
Granulomatous disorders: heterogeneous diseases with variable management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term follow-up of patients with pulmonary sarcoidosis
Y. Garmash (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation)
Source:
International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Session:
Granulomatous disorders: heterogeneous diseases with variable management
Session type:
Thematic Poster
Number:
3010
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Garmash (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation). Long-term follow-up of patients with pulmonary sarcoidosis. 3010
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Long-term follow-up of children diagnosed with pulmonary hypoplasia
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Five years follow-up after pulmonary rehabilitation of patients with COPD
Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes
Year: 2010
Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017
Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
One year follow-up of patients with idiopathic pulmonary fibrosis treated with immunosuppressive therapy
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007
Prognosis of pulmonary sarcoidosis in young patients
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003
Long-term outcome of pulmonary rehabilitation in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 244s
Year: 2003
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up)
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Clinical-radiological and functional follow-up of pulmonary sequelae after COVID-19
Source: Virtual Congress 2021 – Chronic COVID - 19
Year: 2021
Long-term benefits of pulmonary rehabilitation in patients with chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 454s
Year: 2002
Long-term follow-up after endoscopic valve therapy in patients with severe emphysema
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018
The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects
Year: 2011
Early pulmonary hemodynamical changes in systemic sclerosis. A one-year follow-up
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias
Source: ERJ Open Res, 5 (2) 00045-2019; 10.1183/23120541.00045-2019
Year: 2019
Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
One-year observation of iloprost inhalation therapy in patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001
Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021
Long-term effect of low-intensity home-based pulmonary rehabilitation in patients with COPD and non-COPD – a five-year follow-up
Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients
Year: 2007
Longer-term survival in paediatric patients with idiopathic or familial pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept